logo-loader
ASX:RAD OTC:RDPTF

Radiopharm Theranostics Ltd

Receive alerts
Market:
ASX
Price
0.06 AUD
Day Change
-
Market Cap:
$24.93 m
52 weeks high
0.20
52 weeks low
0.06

In brief

Radiopharm Theranostics Ltd is focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.

The company's asset portfolio features four platforms that, combined, target three-quarters of the causes of death from cancer, including treatment for cancers of the lung, breast, head and neck, along with solid tumours like brain metastases and gliomas.

Snapshot

  • Radiopharm Theranostics to present multiple data releases for RAD 301 at European Molecular Imaging Meeting
  • Radiopharm welcomes positive guidance from FDA to advance Pivalate